Actively Recruiting

Age: 18Years +
All Genders
NCT06863844

The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-03-07

210

Participants Needed

1

Research Sites

108 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The genetic characterization of urothelial tumor disease has brought to light important information about the biology of the disease. The evaluation of molecular DNA markers on tumor tissue could be an approach able to provide important information on the possible aggressiveness of the disease and the sensitivity/resistance profile to drugs commonly adopted in the advanced stage. The main objective of this study is to identify specific molecular profiles from DNA capable of predicting the clinical course of the disease and the possible sensitivity/resistance of the disease to systemic treatments

CONDITIONS

Official Title

The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with locally advanced operated or metastatic urothelial cancer in follow-up or treatment
  • Patients aged older than 18 years
  • Patients suffering from locally advanced or metastatic urothelial neoplasia
  • Availability of tumor tissue obtained during surgery on a primary tumor or metastasis or during a diagnostic biopsy
  • Written informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Deceased patients who have not already performed the NGS analysis from clinical practice

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCS Azienda Ospedaliero Universitaria Bologna

Bologna, Italy, 40138

Actively Recruiting

Loading map...

Research Team

F

Francesco Massari, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here